论文部分内容阅读
目的探讨参芪五味子片联合化疗治疗晚期消化道肿瘤的临床疗效。方法共收治经病理确诊不能手术而给予化学治疗的消化道肿瘤68例,随机分为治疗组36例采用参芪五味子片联合化疗治疗,对照组32例采用单纯化疗。结果在近期疗效、中医证候的改善、生存质量、保护骨髓及减轻胃肠道反应方面均明显优于对照组(P<0.05),且未出现明显的毒副作用。结论参芪五味子片联合化疗能显著改善患者的预后和减少不良反应,具有临床使用价值。
Objective To investigate the clinical efficacy of Shenqi Schisandra tablets combined with chemotherapy in the treatment of advanced gastrointestinal tumors. Methods A total of 68 patients with gastrointestinal cancer who were treated by chemotherapy were enrolled in the study. Sixty-six patients were randomly divided into treatment group (36 cases) treated with Shenqi Schisandra tablets combined with chemotherapy, while those in control group (32 cases) treated with chemotherapy alone. Results in the short term efficacy, improvement of TCM syndrome, quality of life, protection of bone marrow and reduce gastrointestinal reactions were significantly better than the control group (P <0.05), and no obvious side effects. Conclusion Shenqi Schisandra tablets combined with chemotherapy can significantly improve the prognosis of patients and reduce adverse reactions, with clinical value.